The leading cause of cervical cancer, which has a cure rate of nearly 100 percent when detected early, is the HPV virus. Speaking about the HPV vaccine, which significantly reduces the risk of cervical cancer, obstetrician-gynecologist Prof. Dr. Çiğdem Yayla Abide says, “Many women think they are too late for the HPV vaccine and that it can only be given at a very young age. There is no upper age limit for the HPV vaccine.”
HPV, which causes no problems or symptoms in some people but leads to genital warts in others and can turn into cancer if left untreated for many years, has been shown by epidemiological studies over the last 10 years to be the most common sexually transmitted infection worldwide. Emphasizing that, although it is a very common infection, many people do not know they have HPV, obstetrician-gynecologist Prof. Dr. Çiğdem Yayla Abide states that people should have regular Pap smear and HPV DNA screening tests.
It is estimated that more than 80 percent of sexually active women and men will contract at least one HPV infection by age 45. In addition to cervical cancer, HPV can also cause vulvar, vaginal and anal cancer, and even oropharyngeal (mouth, throat, larynx) and skin cancer.
According to World Health Organization data, an estimated 625,600 women and 69,400 men worldwide develop HPV-related cancer every year. In 2020, cervical cancer was the fourth leading cause of cancer and cancer deaths in women. Abide says: “Although cervical cancer is very common, it is expected to be eradicated in the coming years through a range of measures. The World Health Organization is working very hard on this. Vaccination and screening programs are very important to reach this goal.” The HPV vaccine is one of the factors that significantly reduce the risk of cervical cancer. Vaccination before exposure to HPV provides the broadest protection.
Abide says, “Many women think they are too late for the HPV vaccine and that it can only be given at a very young age or in childhood. In some countries, the vaccine is recommended for all individuals, both female and male, aged 9 and older (with no upper age limit), while in other countries it is recommended for individuals aged 9–45. The most effective age range is reported to be under 26. For people at high risk of recurrence after treatment due to HPV-related disease and immune deficiency, the vaccine is recommended regardless of age.”
Noting that the vaccine is given as 2 doses up to age 15 and as 3 doses after age 15, at months 0, 2 and 6, Abide states that studies have shown the vaccine remains effective for more than 10 years in women vaccinated between the ages of 27 and 45.
The Vaccine May Still Help Even If You Have Already Contracted HPV
More than 200 types of HPV have been identified; the most common, low-risk types are known to be HPV 6 and 11. Among these 200 types, two in particular, HPV 16 and 18, are held responsible for 70 percent of cervical cancers.
Three types of HPV vaccine are used in our country: the bivalent vaccine, which protects against types 16 and 18; the quadrivalent vaccine, which protects against types 6, 11, 16 and 18; and the 9-valent vaccine, which protects against types 6, 11, 16, 18, 31, 33, 45, 52 and 58. The 9-valent vaccine, which has the broadest coverage and the highest level of protection, is the most widely recommended.
Noting that many people who have contracted HPV ask about getting vaccinated, Abide says: “Vaccines are not useful for treating lesions, because the purpose of the vaccine is to intervene before the virus enters the cell. However, in some cases the vaccine is protective. For example, if someone is positive for type 16, we recommend vaccination because the vaccine can provide protection against type 18. In other words, if you have not contracted a virus type included in the vaccine, the vaccine will protect you against it.”
Noting that side effects are also among the most frequently asked questions about the vaccine, Abide says, “To date, the vaccine has no proven serious side effects. Because the vaccine does not contain any live virus or viral DNA, it does not cause cancer or other HPV-related diseases.”